(Q34448355)

English

Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study (English)

1 reference

Europe PubMed Central

2 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Heart failure with preserved ejection fraction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pulmonary hypertension

1 reference

based on heuristic

inferred from title

8

object named as

Carolyn S P Lam

1 reference

Europe PubMed Central

2 August 2017

13

object named as

Irene M Lang

1 reference

Europe PubMed Central

2 August 2017

author name string

Diana Bonderman

1

1 reference

Europe PubMed Central

2 August 2017

Ingrid Pretsch

2

1 reference

Europe PubMed Central

2 August 2017

Regina Steringer-Mascherbauer

3

1 reference

Europe PubMed Central

2 August 2017

Pavel Jansa

4

1 reference

Europe PubMed Central

2 August 2017

Stephan Rosenkranz

5

1 reference

Europe PubMed Central

2 August 2017

Caroline Tufaro

6

1 reference

Europe PubMed Central

2 August 2017

Andja Bojic

7

1 reference

Europe PubMed Central

2 August 2017

Reiner Frey

9

1 reference

Europe PubMed Central

2 August 2017

Michael Ochan Kilama

10

1 reference

Europe PubMed Central

2 August 2017

Sigrun Unger

11

1 reference

Europe PubMed Central

2 August 2017

Lothar Roessig

12

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 November 2014

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

146

1 reference

Europe PubMed Central

2 August 2017

5

1 reference

Europe PubMed Central

2 August 2017

1274-1285

1 reference

Europe PubMed Central

2 August 2017

Riociguat for the treatment of pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Pulmonary pressures and death in heart failure: a community study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

The soluble guanylyl cyclase activator YC-1 increases intracellular cGMP and cAMP via independent mechanisms in INS-1E cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Riociguat for the treatment of pulmonary hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

NO-independent, haem-dependent soluble guanylate cyclase stimulators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Recommendations for chamber quantification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Explaining the phenomenon of nitrate tolerance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

6 July 2018

Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

27 October 2018

Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

27 October 2018

Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

27 October 2018

Reference values of right ventricular end-diastolic area defined by ethnicity and gender in a young adult population: the CARDIA study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

27 October 2018

Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

27 October 2018

Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

27 October 2018

Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219342

27 October 2018

Caveat medicus! Pulmonary hypertension in the elderly: a word of caution

1 reference

https://pubmed.ncbi.nlm.nih.gov/24991733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial dysfunction: a pathophysiologic factor in heart failure with preserved ejection fraction

1 reference

https://pubmed.ncbi.nlm.nih.gov/24991733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations

1 reference

https://pubmed.ncbi.nlm.nih.gov/24991733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle

1 reference

https://pubmed.ncbi.nlm.nih.gov/24991733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting

1 reference

https://pubmed.ncbi.nlm.nih.gov/24991733

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1378/CHEST.14-0106

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34448355&oldid=1974447443"